ENOLINK
LIVE

Serial Number

97530152

Owner

Enolink Co., Ltd.

Attorney

Joyce M. Ferraro

Filing Date

Aug 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ENOLINK Trademark

Serial Number: 97530152 • Registration: 8279187

ENOLINK is a trademark filed by Enolink Co., Ltd. on August 2, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Enolink Co., Ltd.

171 Dosan-daero, PSG Building 12F,
Seoul 06037 , KR

Entity Type: 99

Trademark Details

Filing Date

August 2, 2022

Registration Date

June 2, 2026

Published for Opposition

April 14, 2026

Goods & Services

Downloadable and recorded database management computer software; downloadable and recorded computer software for data processing in the fields of public health, healthcare, pharmaceuticals, vaccines, biologics, medical devices, medical diagnostics, biomedical research and development, clinical trials, and post-market data; downloadable and recorded computer software for software application integration and database integration; downloadable and recorded computer software for creating searchable databases of information and data in the fields of public health, healthcare, pharmaceuticals, vaccines, biologics, medical devices, medical diagnostics, biomedical research and development, clinical trials, and post-market data; downloadable and recorded computer software for providing, analyzing and generating reports; downloadable and recorded computer software, downloadable and recorded computer programs and downloadable and recorded computer systems for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, and information in the fields of public health, healthcare, pharmaceuticals, vaccines, biologics, medical devices, medical diagnostics, biomedical research and development, clinical trials, and post-market data; downloadable and recorded software for data analytics in the fields of public health, healthcare, pharmaceutical and biomedical research and development, clinical trials, and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, and the provision of medical and healthcare services; downloadable computer software for accessing and managing computer databases containing information in the pharmaceutical and medical field; downloadable computer search engine software for accessing and providing up-to-date scientific, medical, and clinical information, and for accessing and providing news information of general interest; downloadable and recorded computer software for accessing, controlling and managing data and information related to healthcare services and patient medical information; all of the foregoing for use in the field of healthcare data

Business consulting and business information services; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; business advisory, business consultancy, and business information services; market intelligence research services in the fields of pharmaceuticals, biomedicine, clinical trials, marketing of medicines and commercial post-launching of medicines, and market intelligence research services in the fields of epidemiological research, pharmaco-technological research, public health and healthcare; competitive intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, marketing of medicines and epidemiology, pharmaco-epidemiological research, public health and healthcare; professional business data analysis, business consultancy, and statistical analysis for business purposes in the fields of public health, healthcare, biomedicine, pharmaceuticals, clinical trials, post-authorization research for pharmaceuticals and commercial post-launching of medicines, epidemiological research, pharmaco-epidemiological research and research evaluating epidemiological outcomes; providing commercial information regarding market intelligence services and competitive intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, marketing of medicines and commercial post-launching of medicines, epidemiological research, pharmaco-epidemiological research, public health and healthcare from an online database; arranging of commercial and business contacts in the fields of scientific research and medical communities; provision of business information in the field of healthcare via global computer networks; compilation of data into computer databases, analysis of business data and professional business data analysis for the pharmaceutical and biomedical industries; compilation of data into computer databases, analysis of business data and professional business data analysis for the medical, public health and healthcare industries; providing market intelligence services concerning reimbursement comparative evaluation, namely, market intelligence services for drug pricing and insurance coverage and market intelligence services to healthcare organizations; business analysis of insurance claims data from health and healthcare organizations for commercial purposes; business services provided to the healthcare industry, namely, the collection, reporting, and professional business data analysis of healthcare data for business purposes; compiling business data for market research and market analysis purposes in the fields of public health and healthcare, pharmaceuticals, biomedicine, clinical trials, and post-authorization research for the marketing of medicines and commercial post-launching of medicines

Industrial analysis services being industrial research in the fields of public health, healthcare, pharmaceuticals, vaccines, biologics, medical devices, medical diagnostics, biomedical research and development, clinical trials, and post-market data; design and development of computer software for use in the field of healthcare data; medical and scientific research, namely, conducting clinical trials for others; providing temporary use of online non-downloadable computer software for writing and publishing online journals and blogs; scientific research and technological research in the fields of public health, healthcare, pharmaceuticals, vaccines, biologics, medical devices, medical diagnostics, biomedical research and development, clinical trials, and post-market data and development in the fields of public health, healthcare, pharmaceuticals, vaccines, biologics, medical devices, medical diagnostics, biomedical research and development, clinical trials, and post-market data; new product design and development of medical technology, all in the fields of pharmaceuticals, vaccines, biologics, medical devices, and medical diagnostics; scientific research in the fields of pharmaceutical, biomedical and biological therapies; Industrial analysis and research services being industrial research in the fields of public health, healthcare, pharmaceuticals, vaccines, biologics, medical devices, medical diagnostics, biomedical research and development, clinical trials, and post-market data; data processing analysis services, namely, providing temporary use of non-downloadable software for evaluation of data in the fields of prescription, and supply of pharmaceuticals, vaccines, biologics, medical devices, medical diagnostics, and biomedical goods; development and creation of computer programs for analysis and processing of data; pharmaceutical and biomedical research services, namely, post-authorization research of medicines; epidemiological research services; pharmaco-epidemiological research services being medical research in the field of epidemiology; providing temporary online use of non-downloadable software applications accessible via a web site for performing analytics of data for use in the fields of public health and healthcare, pharmaceuticals, biomedicine, clinical trials and post-authorization research for the marketing of medicines and commercial post-launching of medicines, epidemiological research and pharmaco-epidemiological research; providing online information in the fields of pharmaceutical research, biomedical research, epidemiological research, pharmaco-epidemiological research and medical and scientific research data from clinical trials from a computer database or the Internet; providing scientific research information in the fields of public health and healthcare, biomedicine, pharmaceuticals, and clinical trials; providing temporary online use of non-downloadable software applications accessible via a web site for data analytics and financial analytics for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services; provision of non-downloadable database management software for use in the field of healthcare data; data security services, namely, computer security threat analysis for protecting data; computer services for data analysis, namely, computer programming services for data processing for use in the field of healthcare data; computer design services for developing data processing systems for use in the field of healthcare data; updating of software and leasing of computer software for data processing; software development services for developing data processing systems for use in the field of healthcare data; software development services for data processing computer software for use in the field of healthcare data; management of data processing computer software for managing data programs for use in the field of healthcare data; software engineering services for data processing for use in the field of healthcare data; medical illness prediction services, namely, providing temporary use of online non-downloadable software for data analysis services for use in making medical diagnoses; technological support for medical diagnostic computer software, namely, troubleshooting of computer problems for medical diagnostic computer software; technological consultation in the field of artificial intelligence

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 2, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 2, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 14, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 14, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 8, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 17, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 17, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 17, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 17, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 9, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 9, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 11, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 11, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 11, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2025 CRFA
ASSIGNED TO LIE
Jul 22, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 15, 2025 ERSI
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 11, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 11, 2025 XELR
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 17, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 17, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 17, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 16, 2024 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 11, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 11, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jan 11, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 29, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 29, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 28, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 28, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 29, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 29, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 29, 2023 CNRT
ASSIGNED TO EXAMINER
May 19, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 23, 2022 NWOS
NEW APPLICATION ENTERED
Aug 5, 2022 NWAP